Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

  • This share is currently suspended. It was suspended at a price of 7.23
  • There is currently no data for TRX

Acquisition

20 Jan 2005 07:00

Torex Retail PLC20 January 2005 20th January 2005 Torex Retail plc expands UK Petroleum Business with £2.1m acquisition of Petroleum Services Business Torex Retail plc ("Torex Retail"), the UK's market leader in retail IT systems,today announces the completion of the £2.1m acquisition of Flexiline ForecourtServices Limited ("Flexiline"). Flexiline specialises in the installation andservicing of equipment in petrol filling stations. The £2.1m consideration willbe satisfied by the payment of £1.05m in cash and £1.05m by the issue of1,288,343 new Torex Retail shares. Flexiline, based in Hertfordshire, provides a range of forecourt servicesincluding the project management of service station redevelopment, petrol pumpand system refurbishment, forecourt equipment installation and servicing. Thecompany has grown steadily through winning significant service contracts frommajor retailing groups and achieved sales of £2.5m for the 12 months ended 31stOctober 2004. Flexiline will become part of Torex Retail's expanding Petroleum and ConvenienceDivision and will complement the range of products and services provided for theUK retail petroleum market. Rob Loosemore, Executive Chairman of Torex Retail plc, commented: "The acquisition of Flexiline will add depth to our service offering in theretail petroleum sector. Over the next few years there will be increaseddevelopment and refurbishment activity on forecourts with the introduction ofnew fuels, environmental protection legislation and the addition of outdoorpayment terminals on forecourts. We will now be even better placed to takeadvantage of this increased activity. Flexiline has established an enviable reputation in the market and I expectthat, with the backing of Torex Retail, the company will be in a better positionto win new business from major oil companies. The market is dominated by theservice departments of pump companies and there is no independent company sowell equipped as Flexiline to offer high quality service on the full range ofequipment at filling stations." - ends - Enquiries: Torex Retail plc Citigate Dewe RogersonRob Loosemore, Executive Chairman Seb Hoyle / Ginny PulbrookRichard Thompson, Finance Director Freida MooreTelephone: +44 (0) 870 050 9900 Telephone: +44 (0) 20 7638 9571 Application will be made for the 1,288,343 new shares to be issued pursuant tothe consideration for the acquisition to be admitted to trading on AIM.Admission is expected to become effective on 25 January 2005. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
22nd Nov 20227:00 amRNSDistribution agreement - OrthoPure® XT in Germany
14th Nov 20226:05 pmRNSHolding(s) in Company
7th Nov 20222:35 pmRNSHolding(s) in Company
29th Sep 202210:13 amRNSDirector/PDMR Shareholding
27th Sep 20227:15 amEQSHardman & Co Research on Tissue Regenix (TRX): Operating leverage
7th Sep 20227:00 amRNSHalf-year Report
22nd Aug 20223:31 pmRNSHolding(s) in Company
18th Aug 20225:36 pmRNSHolding(s) in Company
18th Aug 20222:10 pmRNSHolding(s) in Company
11th Aug 20224:30 pmEQSHardman & Co Research: Q&A on Tissue Regenix Group plc: Significantly undervalued which should correct
11th Aug 202212:46 pmRNSHolding(s) in Company
11th Aug 202212:17 pmRNSHolding(s) in Company
11th Aug 20227:00 amRNSConfirmation of Interim Results
5th Aug 20223:19 pmRNSHolding(s) in Company
1st Aug 20223:14 pmRNSHolding(s) in Company
19th Jul 20222:30 pmEQSHardman & Co Research : Tissue Regenix (TRX): Strong 1H’22 sales suggest upside potential
19th Jul 20227:00 amRNSHalf Year Trading Update and Notice of Results
18th Jul 20222:42 pmRNSHolding(s) in Company
18th Jul 20221:33 pmRNSHolding(s) in Company
15th Jul 20225:29 pmRNSHolding(s) in Company
27th Jun 20226:04 pmRNSHolding(s) in Company
27th Jun 202212:58 pmRNSHolding(s) in Company
16th Jun 20221:27 pmRNSExercise of Options and Total Voting Rights
28th Apr 20227:00 amRNSOrthoPure®XT clinical results presentation
26th Apr 20224:19 pmRNSResult of AGM
20th Apr 20224:26 pmRNSDirector/PDMR Shareholding
19th Apr 20227:15 amEQSHardman & Co Research: Tissue Regenix (TRX) On pathway to sustainability
8th Apr 20227:00 amRNSGrant of share options
6th Apr 20222:59 pmRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSFinal year results for the year ended 31 Dec 2021
9th Mar 20227:00 amRNSDistribution agreement for OrthoPure® XT
2nd Mar 20227:00 amRNSNotice of Results
10th Feb 20223:45 pmRNSAdditional Director Disclosures
27th Jan 20227:00 amRNSFull Year Trading update
23rd Dec 20217:00 amRNSDirector/PDMR Shareholding
21st Dec 20212:06 pmRNSSecond Price Monitoring Extn
21st Dec 20212:01 pmRNSPrice Monitoring Extension
19th Oct 20211:15 pmEQSHardman & Co Research: Tissue Regenix (TRX): Faster-than-anticipated recovery
8th Oct 20217:00 amRNSHolding(s) in Company
5th Oct 20214:44 pmRNSHolding(s) in Company
28th Sep 20217:00 amRNSHolding(s) in Company
24th Sep 20212:05 pmRNSDirector/PDMR Shareholding
9th Sep 20214:35 pmRNSDirector/PDMR Shareholding
8th Sep 20217:00 amRNSHalf-year Report
1st Sep 20217:00 amRNSLaunch of DermaPure® Meshed and VNEWTM
1st Sep 20217:00 amRNSNotice of Results
16th Aug 20217:00 amRNSHolding(s) in Company
14th Jul 20213:15 pmEQSHardman & Co Research: Q&A with Dr Martin Hall on Tissue Regenix Group Plc: New capacity now on stream
30th Jun 202111:56 amEQSHardman & Co Research: Tissue Regenix (TRX): Poised for growth
29th Jun 20211:00 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.